Daihan Pharmaceutical Coltd Stock Shares Owned By Insiders
| 023910 Stock | KRW 28,500 50.00 0.18% |
Daihan Pharmaceutical CoLtd fundamentals help investors to digest information that contributes to Daihan Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Daihan Stock. The fundamental analysis module provides a way to measure Daihan Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Daihan Pharmaceutical stock.
Daihan |
Daihan Pharmaceutical CoLtd Company Shares Owned By Insiders Analysis
Daihan Pharmaceutical's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Daihan Pharmaceutical Shares Owned By Insiders | 34.84 % |
Most of Daihan Pharmaceutical's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Daihan Pharmaceutical CoLtd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 34.84% of Daihan Pharmaceutical CoLtd are shares owned by insiders. This is 129.51% higher than that of the Healthcare sector and significantly higher than that of the Pharmaceuticals industry. The shares owned by insiders for all Republic of Korea stocks is notably lower than that of the firm.
Daihan Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Daihan Pharmaceutical's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Daihan Pharmaceutical could also be used in its relative valuation, which is a method of valuing Daihan Pharmaceutical by comparing valuation metrics of similar companies.Daihan Pharmaceutical is currently under evaluation in shares owned by insiders category among related companies.
Daihan Fundamentals
| Return On Equity | 12.49 | |||
| Return On Asset | 0.0677 | |||
| Profit Margin | 0.10 % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 148.23 B | |||
| Shares Outstanding | 6 M | |||
| Shares Owned By Insiders | 34.84 % | |||
| Shares Owned By Institutions | 13.66 % | |||
| Price To Earning | 11.74 X | |||
| Price To Sales | 0.93 X | |||
| Revenue | 171.46 B | |||
| Gross Profit | 56.19 B | |||
| EBITDA | 39.72 B | |||
| Net Income | 22.67 B | |||
| Cash And Equivalents | 83.73 B | |||
| Total Debt | 14 B | |||
| Debt To Equity | 0.15 % | |||
| Current Ratio | 3.12 X | |||
| Cash Flow From Operations | 40.62 B | |||
| Target Price | 58000.0 | |||
| Beta | 0.53 | |||
| Market Capitalization | 182.1 B | |||
| Total Asset | 272.54 B | |||
| Retained Earnings | 67.17 B | |||
| Working Capital | 33.04 B | |||
| Current Asset | 75.05 B | |||
| Current Liabilities | 42.01 B | |||
| Z Score | 7.8 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 272.54 B |
About Daihan Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Daihan Pharmaceutical CoLtd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Daihan Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Daihan Pharmaceutical CoLtd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Daihan Pharmaceutical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Daihan Pharmaceutical's short interest history, or implied volatility extrapolated from Daihan Pharmaceutical options trading.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Daihan Pharmaceutical CoLtd. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Daihan Stock analysis
When running Daihan Pharmaceutical's price analysis, check to measure Daihan Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Daihan Pharmaceutical is operating at the current time. Most of Daihan Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Daihan Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Daihan Pharmaceutical's price. Additionally, you may evaluate how the addition of Daihan Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |